Global private equity firm Permira has appointed Andy Eckert as a senior adviser to its global technology team, focusing on healthcare technology investments. Eckert will also work with the firm’s healthcare team on broader opportunities in the sector.
Eckert has over 30 years of experience managing and growing healthcare companies. He currently serves on the board of directors of Becton, Dickinson and Company, a global medical technology leader, and was most recently CEO of Zelis, a payments technology and cost containment platform which aims to modernise the financial healthcare system. Eckert also previously served as chairman of the board of directors at Varian, a company dedicated to innovative cancer care that became part of Siemens Healthineers through a $16.4bn acquisition in 2021.
Prior to this, Eckert was the CEO of Acelity, a global provider of wound care solutions and products. Under his leadership, Acelity accelerated top-line growth and was ultimately sold to 3M Corporation for $6.7 billion. Eckert has also served as CEO of numerous other healthcare companies including TriZetto, Valence Health, CRC Health Group, Eclipsys Corporation and SumTotal. He began his career at ADAC Laboratories, which included four years asc and CEO until its sale to Philips Medical Systems.
